Results
|
|
61.
|
|
|
|
62.
|
|
|
|
63.
|
|
|
|
64.
|
|
|
|
65.
|
|
|
|
66.
|
|
|
|
67.
|
An outbreak of hepatitis A among cancer patients treated with interleukin-2 and lymphokine-activated killer cells. [electronic resource] by
- Weisfuse, I B
- Graham, D J
- Will, M
- Parkinson, D
- Snydman, D R
- Atkins, M
- Karron, R A
- Feinstone, S
- Rayner, A A
- Fisher, R I
Producer: 19900427
In:
The Journal of infectious diseases vol. 161
Availability: No items available.
|
|
|
68.
|
|
|
|
69.
|
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. [electronic resource] by
- Condra, J H
- Schleif, W A
- Blahy, O M
- Gabryelski, L J
- Graham, D J
- Quintero, J C
- Rhodes, A
- Robbins, H L
- Roth, E
- Shivaprakash, M
Producer: 19950504
In:
Nature vol. 374
Availability: No items available.
|
|
|
70.
|
Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding site. [electronic resource] by
- Sardana, V V
- Schlabach, A J
- Graham, P
- Bush, B L
- Condra, J H
- Culberson, J C
- Gotlib, L
- Graham, D J
- Kohl, N E
- LaFemina, R L
Producer: 19940404
In:
Biochemistry vol. 33
Availability: No items available.
|
|
|
71.
|
Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro. [electronic resource] by
- Cordingley, M G
- LaFemina, R L
- Callahan, P L
- Condra, J H
- Sardana, V V
- Graham, D J
- Nguyen, T M
- LeGrow, K
- Gotlib, L
- Schlabach, A J
Producer: 19910110
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 87
Availability: No items available.
|
|
|
72.
|
Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting. [electronic resource] by
- Levy, D G
- Stergachis, A
- McFarland, L V
- Van Vorst, K
- Graham, D J
- Johnson, E S
- Park, B J
- Shatin, D
- Clouse, J C
- Elmer, G W
Producer: 20000316
In:
Clinical therapeutics vol. 22
Availability: No items available.
|
|
|
73.
|
Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors. [electronic resource] by
- Byrnes, V W
- Emini, E A
- Schleif, W A
- Condra, J H
- Schneider, C L
- Long, W J
- Wolfgang, J A
- Graham, D J
- Gotlib, L
- Schlabach, A J
Producer: 19941017
In:
Antimicrobial agents and chemotherapy vol. 38
Availability: No items available.
|
|
|
74.
|
Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years. [electronic resource] by
- Shaw, F E
- Graham, D J
- Guess, H A
- Milstien, J B
- Johnson, J M
- Schatz, G C
- Hadler, S C
- Kuritsky, J N
- Hiner, E E
- Bregman, D J
Producer: 19880218
In:
American journal of epidemiology vol. 127
Availability: No items available.
|
|
|
75.
|
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. [electronic resource] by
- Condra, J H
- Holder, D J
- Schleif, W A
- Blahy, O M
- Danovich, R M
- Gabryelski, L J
- Graham, D J
- Laird, D
- Quintero, J C
- Rhodes, A
- Robbins, H L
- Roth, E
- Shivaprakash, M
- Yang, T
- Chodakewitz, J A
- Deutsch, P J
- Leavitt, R Y
- Massari, F E
- Mellors, J W
- Squires, K E
- Steigbigel, R T
- Teppler, H
- Emini, E A
Producer: 19970123
In:
Journal of virology vol. 70
Availability: No items available.
|